Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dieta Health is a digital health company focused on digestive disorders, especially irritable bowel syndrome, using a mobile app, AI analytics, and virtual care services. The company developed a proprietary stool image recognition system that converts smartphone images of stool into objective clinical data, alongside tracking of diet, symptoms, medications, and lifestyle factors. Dieta has used this technology to support patient management, telehealth services, and optimization of pharmaceutical and academic clinical trials in gastroenterology. Its offering combines software, machine learning, and clinician support from gastroenterologists, dietitians, and coaches to deliver personalized digestive health recommendations. In March 2025, Dieta Health was acquired by Cylinder to expand AI-driven digestive care capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dieta Health.